Vitiligo

被引:687
作者
Ezzedine, Khaled [1 ,2 ]
Eleftheriadou, Viktoria [3 ]
Whitton, Maxine [3 ]
van Geel, Nanja [4 ]
机构
[1] Hop Pellegrin, Natl Ctr Rare Skin Disorders, Dept Dermatol & Paediat Dermatol, F-33076 Bordeaux, France
[2] Univ Bordeaux 2, INSERM, U1035, F-33076 Bordeaux, France
[3] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England
[4] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium
关键词
QUALITY-OF-LIFE; DEPIGMENTATION THERAPY; KOEBNERS PHENOMENON; T-CELLS; INCREASED SENSITIVITY; GENERALIZED VITILIGO; SUSCEPTIBILITY LOCI; CHILDHOOD VITILIGO; HUMAN MELANOCYTES; IMMUNE-RESPONSE;
D O I
10.1016/S0140-6736(14)60763-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitiligo, an acquired pigmentary disorder of unknown origin, is the most frequent cause of depigmentation worldwide, with an estimated prevalence of 1%. The disorder can be psychologically devastating and stigmatising, especially in dark skinned individuals. Vitiligo is clinically characterised by the development of white macules due to the loss of functioning melanocytes in the skin or hair, or both. Two forms of the disease are well recognised: segmental and non-segmental vitiligo (the commonest form). To distinguish between these two forms is of prime importance because therapeutic options and prognosis are quite different. The importance of early treatment and understanding of the profound psychosocial effect of vitiligo will be emphasised throughout this Seminar.
引用
收藏
页码:74 / 84
页数:11
相关论文
共 118 条
[61]   4-tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: Relevance to vitiligo [J].
Kroll, TM ;
Bommiasamy, H ;
Boissy, RE ;
Hernandez, C ;
Nickoloff, BJ ;
Mestril, R ;
Le Poole, IC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) :798-806
[62]   A review of the worldwide prevalence of vitiligo in children/adolescents and adults [J].
Krueger, Christian ;
Schallreuter, Karin Uta .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (10) :1206-1212
[63]  
Le Poole I C, 1993, Exp Dermatol, V2, P145
[64]   Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL) [J].
Lilly, Evelyn ;
Lu, Phoebe D. ;
Borovicka, Judy H. ;
Victorson, David ;
Kwasny, Mary J. ;
West, Dennis P. ;
Kundu, Roopal V. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (01) :E11-E18
[65]   Clinical profiles of vitiligo in China: an analysis of 3742 patients [J].
Liu, JB ;
Li, M ;
Yang, S ;
Gui, JP ;
Wang, HY ;
Du, WH ;
Zhao, XY ;
Ren, YQ ;
Zhu, YG ;
Zhang, XJ .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2005, 30 (04) :327-331
[66]   Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo [J].
Maresca, V ;
Roccella, M ;
Roccella, F ;
Camera, E ;
DelPorto, G ;
Passi, S ;
Grammatico, P ;
Picardo, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) :310-313
[67]   Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo [J].
Mosenson, Jeffrey A. ;
Zloza, Andrew ;
Nieland, John D. ;
Garrett-Mayer, Elizabeth ;
Eby, Jonathan M. ;
Huelsmann, Erica J. ;
Kumar, Previn ;
Denman, Cecele J. ;
Lacek, Andrew T. ;
Kohlhapp, Frederick J. ;
Alamiri, Ahmad ;
Hughes, Tasha ;
Bines, Steven D. ;
Kaufman, Howard L. ;
Overbeck, Andreas ;
Mehrotra, Shikhar ;
Hernandez, Claudia ;
Nishimura, Michael I. ;
Guevara-Patino, Jose A. ;
Le Poole, I. Caroline .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (174)
[68]   HSP70i is a critical component of the immune response leading to vitiligo [J].
Mosenson, Jeffrey A. ;
Zloza, Andrew ;
Klarquist, Jared ;
Barfuss, Allison J. ;
Guevara-Patino, Jose A. ;
Le Poole, I. Caroline .
PIGMENT CELL & MELANOMA RESEARCH, 2012, 25 (01) :88-98
[69]   VITILIGO - RETROSPECT [J].
NAIR, BKH .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1978, 17 (09) :755-757
[70]   DETECTION OF ANTIBODIES TO MELANOCYTES IN VITILIGO BY SPECIFIC IMMUNOPRECIPITATION [J].
NAUGHTON, GK ;
EISINGER, M ;
BYSTRYN, JC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 81 (06) :540-542